Detalhe da pesquisa
1.
Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors.
J Cell Mol Med
; 17(11): 1397-409, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24251790
2.
Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia.
J Med Chem
; 61(10): 4348-4369, 2018 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29683667
3.
Fragment-based ligand design of novel potent inhibitors of tankyrases.
J Med Chem
; 56(11): 4497-508, 2013 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23672613